Cited by CrossRef (18)

  1. Yu Jin Cho, Youn-Hee Lim, Jae Moon Yun, Hyung-Jin Yoon, Minseon Park. Sex- and age-specific effects of energy intake and physical activity on sarcopenia. Sci Rep 2020;10
    https://doi.org/10.1038/s41598-020-66249-6
  2. Hyuktae Kwon. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:76
    https://doi.org/10.7570/jomes19068
  3. Yoowon Kwon, Su Jin Jeong. Relative Skeletal Muscle Mass Is an Important Factor in Non-Alcoholic Fatty Liver Disease in Non-Obese Children and Adolescents. JCM 2020;9:3355
    https://doi.org/10.3390/jcm9103355
  4. Alessandro Mantovani, Giovanni Targher, Giacomo Zoppini. Nonalcoholic Fatty Liver Disease and Implications for Older Adults with Diabetes. Clinics in Geriatric Medicine 2020;36:527
    https://doi.org/10.1016/j.cger.2020.04.010
  5. Shelley E. Harris, Toryn M. Poolman, Anastasia Arvaniti, Roger D. Cox, Laura L. Gathercole, Jeremy W. Tomlinson. The American lifestyle-induced obesity syndrome diet in male and female rodents recapitulates the clinical and transcriptomic features of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. American Journal of Physiology-Gastrointestinal and Liver Physiology 2020;319:G345
    https://doi.org/10.1152/ajpgi.00055.2020
  6. Goh Eun Chung, Hyo Eun Park, Heesun Lee, Min Joo Kim, Su-Yeon Choi, Jeong Yoon Yim, Ji Won Yoon. Sarcopenic Obesity Is Significantly Associated With Coronary Artery Calcification. Front. Med. 2021;8
    https://doi.org/10.3389/fmed.2021.651961
  7. Goh Eun Chung, Ji Won Yoon. Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:160
    https://doi.org/10.7570/jomes20046
  8. Pegah Golabi, Lynn Gerber, James M. Paik, Rati Deshpande, Leyla de Avila, Zobair M. Younossi. Contribution of sarcopenia and physical inactivity to mortality in people with non-alcoholic fatty liver disease. JHEP Reports 2020;2:100171
    https://doi.org/10.1016/j.jhepr.2020.100171
  9. Evangelos Cholongitas, Dimitrios Tsilingiris, Panagiota Diamantopoulou, Elpida Mastrogianni, Anastasios Tentolouris, Dimitrios Karagiannakis, Ioannis Moyssakis, George V. Papatheodoridis, Nikolaos Tentolouris. Association of cardiovascular factors in diabetic patients with non-alcoholic fatty liver disease. Hormones 2021
    https://doi.org/10.1007/s42000-021-00334-x
  10. David J. Hanna, Scott T. Jamieson, Christine S. Lee, Christopher A. Pluskota, Nicole J. Bressler, Peter N. Benotti, Sandeep Khurana, David D. K. Rolston, Christopher D. Still. “Bioelectrical impedance analysis in managing sarcopenic obesity in NAFLD”. Obes Sci Pract 2021;7:629
    https://doi.org/10.1002/osp4.509
  11. Yun Kim. Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life 2021;11:250
    https://doi.org/10.3390/life11030250
  12. Sophia Marie-Therese Schmitz, Lena Schooren, Andreas Kroh, Alexander Koch, Christine Stier, Ulf Peter Neumann, Tom Florian Ulmer, Patrick Hamid Alizai. Association of Body Composition and Sarcopenia with NASH in Obese Patients. JCM 2021;10:3445
    https://doi.org/10.3390/jcm10153445
  13. Goh-Eun Chung, Hyo-Eun Park, Min-Joo Kim, Min-Sun Kwak, Jong-In Yang, Su-Jin Chung, Jeong-Yoon Yim, Ji-Won Yoon. The Association between Low Muscle Mass and Hepatic Steatosis in Asymptomatic Population in Korea. Life 2021;11:848
    https://doi.org/10.3390/life11080848
  14. Goh Eun Chung, Ji Won Yoon. Response: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:78
    https://doi.org/10.7570/jomes20009
  15. Junghyun Noh. Sarcopenia as a Novel Risk Factor for Nonalcoholic Fatty Liver Disease. JOMES 2020;29:1
    https://doi.org/10.7570/jomes20017
  16. Tiziana Fernández-Mincone, Felipe Contreras-Briceño, Maximiliano Espinosa-Ramírez, Patricio García-Valdés, Antonio López-Fuenzalida, Arnoldo Riquelme, Juan Pablo Arab, Daniel Cabrera, Marco Arrese, Francisco Barrera. Nonalcoholic fatty liver disease and sarcopenia: pathophysiological connections and therapeutic implications. Expert Review of Gastroenterology & Hepatology 2020;14:1141
    https://doi.org/10.1080/17474124.2020.1810563
  17. Ji-Yeon Seo, Jung-Ho Bae, Min-Sun Kwak, Jong-In Yang, Su-Jin Chung, Jeong-Yoon Yim, Seon-Hee Lim, Goh-Eun Chung. The Risk of Colorectal Adenoma in Nonalcoholic or Metabolic-Associated Fatty Liver Disease. Biomedicines 2021;9:1401
    https://doi.org/10.3390/biomedicines9101401
  18. Chan-Hee Jung. Letter: Sarcopenia Is Significantly Associated with Presence and Severity of Nonalcoholic Fatty Liver Disease (J Obes Metab Syndr 2019;28:129-38). JOMES 2020;29:158
    https://doi.org/10.7570/jomes20018